Dr. rer. nat. Jonas Reinold

• Arzneimittelsicherheitsstudien nach Zulassung (PASS)
• Arzneimittelanwendung und -sicherheit während der Schwangerschaft
• Arzneimittel- und Impfstoffsicherheit
• Sekundärdaten

• Deutsche Gesellschaft für Epidemiologie (DGEpi)

• Anwendung von parenteralen Eisen-(III)-Präparaten in Deutschland
• Generationsübergreifende unerwünschte Arzneimittelwirkungen
• PAS-Studie zu Alemtuzumab
• PAS-Studie zu Nocdurna® (Desmopressin)
• PAS-Studie zu Romosozumab
• PAS-Studie zu Solriamfetol
• PAS-Studie zu Tralokinumab

Ausgewählte BIPS-Veröffentlichungen

• Zeitschriftenartikel mit peer-review

• Reinold J, Kollhorst B, Temme HL, Wentzell N, Haug U. Use of acitretin among girls and women of childbearing age and occurrence of acitretin-exposed pregnancies in Germany. Clinical Drug Investigation. 2023;43(11):865-872.
  https://doi.org/10.1007/s40261-023-01314-2
• Tan EH, Robinson DE, Jödicke A, Mosseveld M, Bodkergaard K, Reyes C, Moayyeri A, Voss A, Marconi E, Lapi F, Reinold J, Verhamme K, Pedersen L, Braitmaier M, De Wilde M, Far Ruiz M, Aragón M, Bosco-Levy P, Lassalle R, Prieto-Alhambra D, Sanchez-Santos M. Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Osteoporosis International. 2023;34(10):1771-1781.
  https://doi.org/10.1007/s00198-023-06837-0
• Wentzell N, Kollhorst B, Reinold J, Haug U. Use of methotrexate in girls and women of childbearing age, occurrence of methotrexate-exposed pregnancies and their outcomes in Germany: A claims data analysis. Clinical Drug Investigation. 2023;43(2):109-117.
  https://doi.org/10.1007/s40261-022-01227-6
• Asendorf M, Reinold J, Schink T, Kollhorst B, Haug U. Abbildbarkeit des sozioökonomischen Status in der pharmakoepidemiologischen Forschungsdatenbank GePaRD: Beschreibung und Anwendung am Beispiel des Zusammenhangs mit Adipositas. GMS Medizinische Informatik, Biometrie und Epidemiologie. 2022;18(1):Doc02.
  https://doi.org/10.3205/mibe000235
• Platzbecker K, Voss A, Reinold J, Elbrecht A, Biewener W, Prieto-Alhambra D, Jödicke A, Schink T. Validation of algorithms to identify acute myocardial infarction, stroke, and cardiovascular death in German health insurance data. Clinical Epidemiology. 2022;14:1351-1361.
  https://doi.org/10.2147/CLEP.S380314
• Reinold J, Braitmaier M, Riedel O, Haug U. Potential of health insurance claims data to predict fractures in older adults: A prospective cohort study. Clinical Epidemiology. 2022;14:1111-1122.
  https://doi.org/10.2147/CLEP.S379002
• de Sordi D, Kappen S, Otto-Sobotka F, Kulschewski A, Weyland A, Gutierrez L, Fortuny J, Reinold J, Schink T, Timmer A. Validity of hospital ICD-10-GM codes to identify anaphylaxis. Pharmacoepidemiology and Drug Safety. 2021;30(12):1643-1652.
  https://doi.org/10.1002/pds.5348
• Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthan S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits L, Forstner M, Intravenous Iron Consortium, Benichou J, Bircher AJ, Garbe E, Rampton D, Gutierrez L. Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and Drug Safety. 2021;30(10):1447-1457.
  https://dx.doi.org/10.1002/pds.5319
• Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. Hip fracture risk in antiepileptic drug initiators and non-initiators with Alzheimer's disease. Clinical Epidemiology. 2021;13:295-307.
  https://doi.org/10.2147/CLEP.S278306
• Reinold J, Braitmaier M, Riedel O, Haug U. Anticholinergic burden: First comprehensive analysis using claims data shows large variation by age and sex. PLOS ONE. 2021;16(6):e0253336.
  https://doi.org/10.1371/journal.pone.0253336
• Pisa F, Reinold J, Kollhorst B, Haug U, Schink T. Individual antidepressants and the risk of fractures in older adults: A new user active comparator study. Clinical Epidemiology. 2020;12:667-678.
  https://doi.org/10.2147/CLEP.S222888
• Reinold J, Schäfer W, Christianson L, Barone-Adesi F, Riedel O, Pisa F. Anticholinergic burden and fractures: A systematic review with methodological appraisal. Drugs & Aging. 2020;37(12):885-897.
  https://doi.org/10.1007/s40266-020-00806-6
• Pisa F, Reinold J, Kollhorst B, Haug U, Schink T. Antidepressants and the risk of traumatic brain injury in the elderly: Differences between individual agents. Clinical Epidemiology. 2019;11:185-196.
  https://doi.org/10.2147/CLEP.S173667
• Reinold J, Palese F, Romanese F, Logroscino G, Riedel O, Pisa F. Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications. International Journal of Geriatric Psychiatry. 2019;34(6):868-880.
  https://doi.org/10.1002/gps.5084
• Reinold J, Schäfer W, Christianson L, Barone-Adesi F, Riedel O, Pisa F. Anticholinergic burden and fractures: A protocol for a methodological systematic review and meta-analysis. BMJ Open. 2019;9:e030205.
  https://doi.org/10.1136/bmjopen-2019-030205

• Vorträge bei wissenschaftlichen Tagungen

• Reinold J, Riedel O, Pisa F. Use of medication with anticholinergic activity and anticholinergic burden in older adults with dementia. Bremen. 2018.

• Poster bei wissenschaftlichen Tagungen

• Reinold J, Kollhorst B, Haug U. Use of isotretinoin in girls and women of childbearing age: Description of drug utilization and exposure during pregnancy. Copenhagen, Denmark. 2022.
• Reinold J, Riedel O, Haug U. Substantial differences in the anticholinergic burden across sex and age groups in a large population-based sample. online poster. 2020.
• Reinold J, Schäfer W, Christianson L, Barone-Adesi F, Riedel O, Pisa F. Anticholinergic burden and fractures in older adults: Results from a methodological systematic review. online poster. 2020.

• Weitere Publikationen